This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Kenichi Demizu: Innovator in Pharmaceutical Compounds
Introduction
Kenichi Demizu is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thienotriazolodiazepine compounds. His research focuses on the development of compounds that exhibit PAF-antagonistic activity, which are useful in the prevention and treatment of various PAF-induced diseases.
Latest Patents
Demizu holds a patent for thienotriazolodiazepine compounds and their pharmaceutical uses. The patent describes a thienotriazolodiazepine compound of a specific formula, or a pharmaceutically acceptable acid addition salt thereof. This compound has potential applications in treating conditions related to PAF-induced diseases.
Career Highlights
Kenichi Demizu is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been able to apply his expertise in pharmaceutical research. His work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Demizu has collaborated with notable colleagues such as Hiroshi Mikashima and Yoichi Akiyama. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Kenichi Demizu's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatments for various diseases. His work continues to impact the field positively.